株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ファーマコビジランスおよび薬物安全性ソフトウェアの世界市場:2019年~2023年

Global Pharmacovigilance and Drug Safety Software Market 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 881688
出版日 ページ情報 英文 121 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.97円で換算しております。
Back to Top
ファーマコビジランスおよび薬物安全性ソフトウェアの世界市場:2019年~2023年 Global Pharmacovigilance and Drug Safety Software Market 2019-2023
出版日: 2019年06月26日 ページ情報: 英文 121 Pages
概要

ファーマコビジランスおよび薬物安全性ソフトウェアは、有害な薬物事象およびファーマコビジランスデータの作成、分類、評価、レビュー、提出、および保守に使用されます。 新しい分子やバイオシミラーは、発売前に薬の安全性評価を受けています。これは、薬が規制に従って安全基準に確実に準拠するようにするためです。新しい分子実体およびバイオシミラーの認可の増加、ならびに世界中で登録されている臨床試験活動により、ファーマコビジランスおよび薬の安全性ソフトウェアの採用が急増し、その結果、世界のファーマコビジランスおよび薬の安全性ソフトウェア市場が予測期間中に7%に近いCAGRで拡大する見込みです。

当レポートでは、世界のファーマコビジランスおよび薬物安全性ソフトウェア市場について調査分析し、市場規模および成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 調査範囲

  • イントロダクション1
  • イントロダクション2
  • 米ドルの通貨換算レート

第3章 市場状況

  • 市場のエコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第4章 市場規模

  • 市場の定義
  • 市場規模(2018年)
  • 市場規模および予測(2018年〜2023年)

第5章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第6章 市場セグメンテーション:エンドユーザー別

  • 市場セグメンテーション:エンドユーザー別
  • エンドユーザー別比較:市場規模および予測(2018年〜2023年)
  • 製薬およびバイオテクノロジー企業
  • 受託研究機関
  • ビジネスプロセスアウトソーシング
  • 市場機会:エンドユーザー別

第7章 顧客情勢

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較:市場規模および予測(2018年〜2023年)
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 意思決定の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • ファーマコビジランスにおけるAIの統合
  • CROへのファーマコビジランスと医薬品安全性調査のアウトソーシング
  • 医薬品製造および試験におけるクラウド技術の広範な採用

第12章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第13章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO GmbH
  • Oracle Corp.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場ポジショニングの定義

第15章 TECHNAVIOについて

図表
  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Pharmaceutical and biotechnology companies - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Pharmaceutical and biotechnology companies - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Contract research organization - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Contract research organization - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Business process outsourcing - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Business process outsourcing - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: AB Cube - Vendor overview
  • Exhibit 46: AB Cube - Business segments
  • Exhibit 47: AB Cube - Organizational developments
  • Exhibit 48: AB Cube - Key offerings
  • Exhibit 49: ArisGlobal LLC - Vendor overview
  • Exhibit 50: ArisGlobal LLC - Product segments
  • Exhibit 51: ArisGlobal LLC - Organizational developments
  • Exhibit 52: ArisGlobal LLC - Key offerings
  • Exhibit 53: Ennov - Vendor overview
  • Exhibit 54: Ennov - Business segments
  • Exhibit 55: Ennov - Organizational developments
  • Exhibit 56: Ennov - Key offerings
  • Exhibit 57: EXTEDO GmbH - Vendor overview
  • Exhibit 58: EXTEDO GmbH - Business segments
  • Exhibit 59: EXTEDO GmbH - Organizational developments
  • Exhibit 60: EXTEDO GmbH - Key offerings
  • Exhibit 61: Oracle Corp. - Vendor overview
  • Exhibit 62: Oracle Corp. - Business segments
  • Exhibit 63: Oracle Corp. - Organizational developments
  • Exhibit 64: Oracle Corp. - Geographic focus
  • Exhibit 65: Oracle Corp. - Segment focus
  • Exhibit 66: Oracle Corp. - Key offerings
  • Exhibit 67: Validation techniques employed for market sizing
  • Exhibit 68: Definition of market positioning of vendors
目次
Product Code: IRTNTR31560

About this market

Pharmacovigilance and drug safety software are used in the creation, classification, assessment, reviewal, submission, and maintenance of adverse drug events and pharmacovigilance data. Technavio's pharmacovigilance and drug safety software market analysis considers sales from end-users pharmaceutical and biotechnology companies, contract research organization, and business process outsourcing. Our analysis also considers the sales of pharmacovigilance and drug safety software in APAC, Europe, North America, and ROW. In 2018, the pharmaceutical and biotechnology companies segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the release of new drugs in countries such as the US, Japan, and Canada will play a significant role in the pharmaceutical and biotechnology companies segment to maintain its market position. Also, our global pharmacovigilance and drug safety software market report looks at factors such as rising incidence rates of adverse drug events, favorable government regulations and policies, and increasing approvals for new molecules and biosimilars. However, high cost of ownership, installation, and maintenance, concerns related to data safety and security, and issues related to system integration may hamper the growth of the pharmacovigilance and drug safety software industry over the forecast period.

Overview

Increasing approvals for new molecules and biosimilars

New molecules and biosimilars undergo drug safety assessments before their launch in the market. This is to ensure that the drugs comply with safety standards as per regulations. This rise in approval of new molecular entities and biosimilars as well as registered activities of clinical trials globally has resulted in a surge in the adoption of pharmacovigilance and drug safety software which will subsequently lead to the expansion of the global pharmacovigilance and drug safety software market at a CAGR of close to 7% during the forecast period.

Outsourcing pharmacovigilance and drug safety research to CROs

To reduce the operational costs and provide revenue-generating opportunities to the vendors, pharmacovigilance, and drug safety operations are being outsourced to developing economies such as India, China, and the Philippines. This trend is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global pharmacovigilance and drug safety software market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few major players, the global pharmacovigilance and drug safety software market is moderately concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmacovigilance and drug safety software manufacturers, that includes AB Cube, ArisGlobal LLC, Ennov, EXTEDO GmbH, and Oracle Corp.

Also, the pharmacovigilance and drug safety software market analysis report include information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Pharmaceutical and biotechnology companies -
  • Market size and forecast 2018-2023
  • Contract research organization - Market size and forecast 2018-2023
  • Business process outsourcing - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Integration of AI in pharmacovigilance
  • Outsourcing pharmacovigilance and drug safety research to CROs
  • Extensive adoption of cloud technologies in pharmaceutical manufacturing and testing

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO GmbH
  • Oracle Corp.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

Back to Top